PROXY 2015

Company

Arbutus Biopharma Corp

Filed

April 8, 2016

Period of Report

May 19, 2016

Accession Number

0001628280-16-014088

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →